Hiranmoy Das | Biology and Life Sciences | Lifetime achievement Award

Posted on 17/01/202517/01/2025 by ScienceFather

Hiranmoy Das | Biology and Life Sciences | Lifetime achievement Award

Prof Hiranmoy Das, Texas Tech University Health Sciences Center, United States

Prof. Hiranmoy Das, MSc, PhD, FAHA, is a renowned biochemist and pharmacologist with a distinguished career. He holds a Ph.D. from the University of Calcutta and has postdoctoral training from prestigious institutions like Harvard Medical School and the Hyogo Institute of Clinical Research. Currently a Professor at Texas Tech University, his research focuses on cardiovascular stem cell therapies, regenerative medicine, and immunology. He has received numerous awards, including induction into the National Academy of Inventors and the American Heart Association. Prof. Das has authored several publications and holds multiple patents. 🌟📚💉🔬🧬

Publication Profile

Google Scholar

Education

Prof. Hiranmoy Das holds a Ph.D. in Biochemistry from the University of Calcutta (1995) and has extensive academic training in zoology, advanced cytogenetics, immunology, and biology. He completed postdoctoral fellowships at prestigious institutions, including Harvard Medical School (1999-2002) and Hyogo Institute of Clinical Research, Japan (1996-1999). Prof. Das has held prominent roles, such as Professor at Texas Tech University (2016-present) and Associate Professor at The Ohio State University (2008-2016). He also directed cardiovascular stem cell research laboratories. His remarkable career spans over decades, focusing on innovative research in the fields of biochemistry and immunology. 📚💉🔬

Honors and Awards

Prof. Hiranmoy Das, a distinguished researcher and educator, has received numerous accolades for his groundbreaking contributions. In 2024, he was elected as a Fellow of the National Academy of Inventors. He was inducted into the prestigious Sigma Xi in 2023 and awarded the President’s Excellence in Research Award in 2022. As a tenured professor at Texas Tech University, he earned the Chancellor’s Council Distinguished Research Award in 2021. His honors also include the American Heart Association Fellowship (2021) and a Keynote Speaker role at an International Conference in 2018. Earlier awards include the NIH K01 Award and National Merit Scholarship. 🏆🔬🎓

Experiences

Prof. Hiranmoy Das has taught a variety of undergraduate, graduate, and professional courses at TTUHSC, including leadership roles in Pharmaceutical Sciences Research (G) in Spring, Summer, and Fall sessions from 2021 to 2024 📚. He led courses like Clinical Correlation-6 and Integrated Therapy and Practice VII, as well as Experimental Design and Biostatistics 🧪. Prof. Das has mentored students in clinical and research settings, contributing significantly to pharmaceutical education 💡. His commitment to fostering academic growth is reflected in his continued leadership in research-focused courses, impacting future professionals in the field of pharmaceutical sciences 🎓.

PhD Thesis

Prof. Hiranmoy Das appears to be heavily involved in mentoring and advising graduate students, particularly in the fields related to pharmacy, veterinary medicine, and health sciences. His research likely focuses on advanced pharmaceutical sciences, drug development, and therapeutics. With his role in advising students pursuing PhD and MS theses, his research could be centered around pharmaceutical applications, medicinal chemistry, or pharmacology. Given his involvement in both veterinary and pharmacy programs, his research may also bridge the gap between human and veterinary health, focusing on biomedical sciences, drug formulations, and therapeutics for both sectors. 📚💊🐾👩‍🔬👨‍🔬

Research Focus

Hiranmoy Das focuses on molecular and cellular biology, particularly related to vascular biology, immunology, and inflammation. His research delves into the roles of Kruppel-like factor 2 (KLF2) in endothelial cells, immune responses, and its regulatory functions in cardiovascular health. He also investigates autophagy, cell death, and ischemic stroke therapies, emphasizing the use of assays for monitoring these processes. His work highlights the role of phytochemicals in cancer prevention and the immune system’s effector functions. Das has made significant contributions to understanding cellular signaling and disease mechanisms, with implications for therapeutic development. 🔬💉🧬🫀

Publication Profile

Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)¹

Guidelines for the use and interpretation of assays for monitoring autophagy in higher eukaryotes

Guidelines for the use and interpretation of assays for monitoring cell death in higher eukaryotes

Current advances in ischemic stroke research and therapies

MICA engagement by human Vγ2Vδ2 T cells enhances their antigen-dependent effector function

Kruppel-like factor 2 as a novel mediator of statin effects in endothelial cells

Kruppel-like factor 2 (KLF2) regulates proinflammatory activation of monocytes

CD1-mediated γ/δ T cell maturation of dendritic cells

Mengmeng Liu | Biology and Life Sciences | Best Researcher Award

Posted on 14/12/202414/12/2024 by ScienceFather

Mengmeng Liu | Biology and Life Sciences | Best Researcher Award

Ms Mengmeng Liu, Shandong University, China

Mengmeng Liu, Ph.D. 🎓, is a postdoctoral researcher at Shandong University’s State Key Laboratory of Microbial Technology, mentored by Prof. Qingsheng Qi. 🌱🧬 She earned her Ph.D. in Biochemistry and Molecular Biology from the Kunming Institute of Botany, CAS, and a B.Sc. in Biotechnology from Jilin University. Her research focuses on metabolic engineering of Yarrowia lipolytica for sustainable β-carotene and terpene production 🌿🧪, employing NHEJ-mediated mutagenesis and high-throughput screening. Proficient in advanced genetic, molecular biology, and analytical techniques 🔬💻, she has published extensively in high-impact journals and holds patents in microbial biotechnology. 📜⚗️

Publication Profile

Orcid

Education and Experience

Ms. Mengmeng Liu is a dedicated researcher in microbiology and biochemistry. She has been a postdoctoral fellow at the State Key Laboratory of Microbial Technology, Shandong University, under Prof. Qingsheng Qi since September 2019 🧬📚. She earned her Ph.D. in Biochemistry and Molecular Biology from the Kunming Institute of Botany, Chinese Academy of Sciences, under Prof. Junchao Huang in 2019 🌱🔬. Ms. Liu completed her Bachelor’s degree in Biotechnology (Plant Sciences) from Jilin University in 2013 🎓🌿. Her academic journey highlights her commitment to advancing knowledge in microbial and plant biotechnology, contributing to impactful research in these fields. 🌟🧪

Research direction

Mengmeng Liu is a postdoctoral researcher focusing on designing and constructing Yarrowia lipolytica cell factories. Using traditional and cell morphology metabolic engineering, she optimizes yeast metabolism for the green bioproduction of terpenoids like β-carotene using inexpensive substrates. She explores the application of non-homologous end joining (NHEJ) in metabolic engineering of Y. lipolytica, develops methods for mutant library construction, and establishes high-throughput screening for terpenoid compounds. During her Ph.D., Mengmeng worked on designing Shewanella oneidensis cell factories for producing terpenoid compounds (like lutein and astaxanthin) using cheap industrial byproducts. She also contributed to constructing and modifying metabolic pathways in marine microalgae.📦🔬🚀

Representative papers

Mengmeng Liu is an accomplished researcher focused on metabolic and morphological engineering of microbial strains. Her work includes optimizing β-carotene production in Yarrowia lipolytica and mapping nonhomologous end joining-mediated integration for genome-scale mutagenesis. Liu has also explored the high-throughput screening of gene targets for enhancing carotenoid production in oleaginous yeast. Additionally, her research extends to engineering Sphingobium sp. to accumulate various carotenoids using agro-industrial byproducts, and enhancing coproduction of cell-bound zeaxanthin and exopolysaccharides through metabolic engineering. 🌱🔬📊

Research Focus

Mengmeng Liu’s research focuses on genetic and metabolic engineering of Yarrowia lipolytica, an unconventional yeast, for biotechnological applications. Her work includes the development of genetic markers, genome-scale trackable mutagenesis, and efficient production of important compounds like 2′-fucosyllactose and β-carotene. She applies high-throughput screening techniques like flow cytometry to enhance yield and optimize metabolic pathways. Her studies aim to improve the strain’s productivity and sustainability for industrial applications using agro-industrial byproducts and by manipulating cellular processes. 🌱🔍🧬

Publication Top Notes

Development of genetic markers in Yarrowia lipolytica

Efficient production of 2′-fucosyllactose in unconventional yeast Yarrowia lipolytica

Mapping of Nonhomologous End Joining-Mediated Integration Facilitates Genome-Scale Trackable Mutagenesis in Yarrowia lipolytica

Rapid Gene Target Tracking for Enhancing b-Carotene Production Using Flow Cytometry-Based High-Throughput Screening in Yarrowia lipolytica

Engineering Sphingobium sp. to Accumulate Various Carotenoids Using Agro-Industrial Byproducts

Morphological and Metabolic Engineering of Yarrowia lipolytica to Increase β-Carotene Production

Enhanced Coproduction of Cell-Bound Zeaxanthin and Secreted Exopolysaccharides by Sphingobium sp. via Metabolic Engineering and Optimized Fermentation

Illustrating and enhancing the biosynthesis of astaxanthin and docosahexaenoic acid in Aurantiochytrium sp. SK4

Conclusion

Mengmeng Liu’s research is characterized by innovation, interdisciplinary collaboration, and a commitment to sustainable biotechnological solutions. Her outstanding achievements in metabolic engineering, impactful publications, and practical innovations position her as an exemplary candidate for the Best Researcher Award. 🌱📚 Her work embodies the spirit of pushing boundaries and advancing knowledge in the field, making significant contributions to sustainable biotechnology. 🚀🌍

Tao Sun | Biology and Life Sciences | Best Researcher Award

Posted on 16/10/202416/10/2024 by ScienceFather

Tao Sun | Biology and Life Sciences | Best Researcher Award

Prof Tao Sun, Nankai University, China

Prof. Tao Sun is a distinguished researcher with a notable focus on the molecular mechanisms of malignant tumors, drug development, and pharmacology. His research contributions span across numerous high-impact journals and groundbreaking innovations in cancer research. Below is a breakdown of his key published works, which collectively demonstrate his eligibility for the “Best Researcher Award”:

Publication profile

Orcid

Education

Dr. Tao Sun is a distinguished professor and doctoral supervisor at the College of Pharmacy, Nankai University. A National Youth Talent and winner of the Tianjin Distinguished Youth Scholar award, he focuses on malignant tumor mechanisms, drug development, and pharmacology. He has published over 40 papers in leading journals and holds more than 20 authorized patents, with 3 new drugs approved for clinical use. Dr. Sun has led 8 major research projects and mentored students to win gold at the China International College Students’ Innovation Competition. He also earned Nankai University’s “Scholarly Mentor and Beneficial Friend” award 🧬💊📚.

Research focus

Tao Sun’s research primarily focuses on cancer biology, nanotechnology, and pharmacology. His work explores innovative approaches to cancer treatment, such as nanoparticle-loaded circular ssDNA for tumor suppression, promoting wound healing with nanocompounds like Phenytoin silver, and investigating molecular mechanisms behind metastasis in hepatocellular carcinoma. Sun also examines metabolic disorders, developing partial PPARγ agonists to combat insulin resistance and type 2 diabetes. His research applies cutting-edge techniques like click chemistry for drug development and aims to enhance therapeutic efficacy in both oncology and metabolic diseases. 🧬💉🧪🌿💊

Publication top notes

Hsp90β promoted endothelial cell-dependent tumor angiogenesis in hepatocellular carcinoma

Phenytoin silver: A new nanocompound for promoting dermal wound healing via comprehensive pharmacological action

Thymidine phosphorylase promotes metastasis and serves as a marker of poor prognosis in hepatocellular carcinoma

Novel Podophyllotoxin Derivatives as Partial PPARÎ 3 Agonists and their Effects on Insulin Resistance and Type 2 Diabetes

Problems and Solutions in Click Chemistry Applied to Drug Probes

A novel partial agonist of peroxisome proliferator-activated receptor γ with excellent effect on insulin resistance and type 2 diabetes

Conclusion

Prof. Tao Sun’s extensive research in oncology, particularly his work on the molecular drivers of cancer and innovative therapeutic approaches, makes him a strong candidate for the “Best Researcher Award.” His pioneering contributions to cancer biology, drug development, and immunotherapy have had significant impacts in both academia and clinical applications.

Álvaro Torres-Martos | Biology and Life Sciences | Best Researcher Award

Posted on 28/08/202428/08/2024 by ScienceFather

Álvaro Torres-Martos | Biology and Life Sciences | Best Researcher Award

Mr Álvaro Torres-Martos, University of Granada, Spain

Based on the impressive research experience and academic achievements of Mr. Álvaro Torres-Martos, he appears to be a strong candidate for the Best Researcher Award.

Publication profile

google scholar

Research Experience

Mr. Torres-Martos has been deeply involved in cutting-edge research projects. His work as a Bioinformatic Researcher on the ACTIBATE project, focused on exploring therapeutic targets through exercise and brown adipose tissue activation, demonstrates his expertise in bioinformatics. His role as a Pre-doctoral Researcher on the EXOMAIR project, which aims to use explicable artificial intelligence for precision medicine, further highlights his research excellence and potential impact in the field of metabolic health.

Academic Background

With a Bachelor’s degree in Biochemistry and a Master’s in Bioinformatics and Biostatistics, Mr. Torres-Martos has a solid foundation in the sciences, further strengthened by his ongoing pre-doctoral studies and faculty position in Biochemistry and Molecular Biology at the University of Granada. His academic progression reflects a commitment to interdisciplinary research, particularly in bioinformatics and precision medicine.

Research Publications

Mr. Torres-Martos has contributed to high-impact journals, with publications that showcase his expertise in multi-omics, machine learning, and their applications in childhood obesity and insulin resistance. His research has been recognized in well-regarded journals like Artificial Intelligence in Medicine and Translational Psychiatry, with his work cited by other scholars, indicating the relevance and influence of his studies in the scientific community.

Other Achievements

Mr. Torres-Martos’s achievements extend beyond publications. His victory in the III Bioinformatics Datathon and the development of the ObMetrics app highlight his practical contributions to the field. Additionally, his active participation in national and international conferences and completion of specialized courses in data science and bioinformatics demonstrate his dedication to continuous learning and knowledge dissemination.

Conclusion

In conclusion, Mr. Álvaro Torres-Martos has established himself as a highly skilled researcher with a significant impact on the fields of bioinformatics, precision medicine, and metabolic health. His academic background, research experience, and substantial contributions to high-impact journals make him a deserving candidate for the Best Researcher Award. His ongoing commitment to advancing knowledge in bioinformatics and his innovative approaches to addressing complex health issues position him as a leading researcher with a promising future.

Publication top notes

Impact of physical activity and exercise on the epigenome in skeletal muscle and effects on systemic metabolism

Omics data preprocessing for machine learning: A case study in childhood obesity

Body mass index interacts with a genetic-risk score for depression increasing the risk of the disease in high-susceptibility individuals

Human multi-omics data pre-processing for predictive purposes using machine learning: a case study in childhood obesity

Integrative analysis of blood cells DNA methylation, transcriptomics and genomics identifies novel epigenetic regulatory mechanisms of insulin resistance during puberty in …

Multiomics and eXplainable artificial intelligence for decision support in insulin resistance early diagnosis: A pediatric population-based longitudinal study

Leveraging Machine Learning and Genetic Risk Scores for the Prediction of Metabolic Syndrome in Children with Obesity

An Unhealthy Dietary Pattern-Related Metabolic Signature Is Associated with Cardiometabolic and Mortality Outcomes: A Prospective Analysis of the UK Biobank Cohort

Big Data and Machine Learning as Tools for the Biomedical Field

Epigenetic Alterations in the Estrogen Receptor Accompany the Development of Obesity-Associated Insulin Resistance during Sexual Maturation

Steven Goodman | Biology and Life Sciences | Best Researcher Award

Posted on 11/07/202411/07/2024 by ScienceFather

Steven Goodman | Biology and Life Sciences | Best Researcher Award

Prof Steven Goodman, Field Museum of Natural History, United States

Dr. Steven Goodman is a distinguished conservation biologist recognized for his groundbreaking work in biodiversity. He has received numerous awards, including the Biodiversity Leadership Award (2004) and the Aldo Leopold Conservation Award (2018) 🏆. His research and fieldwork, funded by prestigious grants from organizations like the American Museum of Natural History and National Geographic Society, have significantly contributed to the understanding and conservation of avifauna and ecosystems in Egypt and beyond 🌍. An Honorary Fellow of the Association for Tropical Biology and Conservation (2019), Dr. Goodman continues to inspire with his dedication to preserving natural heritage 🌿🦜.

Publication profile

google scholar

Education

📚 With a rich academic journey, this scholar began their educational pursuit at the University of Michigan, USA, where they earned a B.S. 🎓 They continued their studies at the University of Hamburg, Germany, achieving a Ph.D. 🥼 Furthering their expertise, they completed an HDR at the University of Orsay, France 🌍, and were honored with a Docteur Honoris Causa from the University of Antananarivo, Madagascar. 🌟 This distinguished academic path highlights their dedication and significant contributions to their field.

Awards

🌿 Renowned for his contributions to biodiversity, he received the Biodiversity Leadership Award from the Bay and Paul Foundation and the Conservation Leadership Award from WWF in 2004. In 2005, he was named a MacArthur Foundation Fellow. His excellence continued with an Alexander von Humboldt Foundation Fellowship in 2013 and the Aldo Leopold Conservation Award from the American Society of Mammalogists in 2018. Honored as an Honorary Fellow by the Association for Tropical Biology and Conservation in 2019, he recently earned the Certificat de reconnaissance, champion de la Biodiversité, from Madagascar’s Ministre de l’Environnement et du Développement Durable in 2024. 🌍✨

Research focus

The research focus of SM Goodman encompasses a wide range of ecological and evolutionary studies, primarily centered on Madagascar. Goodman’s work includes biodiversity conservation in tropical forests 🌳, ecological niche modeling 📊, and the biogeographic evolution of Madagascar’s unique fauna 🦎. Additionally, Goodman has contributed significantly to understanding species diversity and endemism on the island, including extensive studies on lemurs 🐒 and carnivores 🐆. His research also explores human impacts on ecosystems and the evolutionary history of various species, highlighting the importance of conservation efforts in maintaining biodiversity 🌍. Overall, Goodman’s work aims to protect and preserve Madagascar’s rich natural heritage.